CA
Charles Antoine Janssen
About Charles Antoine Janssen
Data last updated:
Charles Antoine Janssen is a Director at Qure.Ai Technologies Private Limited (since 2022), Nominee Director at Neonatal Care & Research Institute Private Limited (since 2021) and Nominee Director at Sekhmet Technologies Private Limited (since 2021), and holds 6 more current directorships. The companies operate in Healthcare, Internet and Financial Services. The 9 current companies with reported revenue have a combined latest revenue of ₹566 Cr; the largest is Qure.Ai Technologies Private Limited at ₹190 Cr (FY 2025). Earlier, Charles Antoine Janssen was a Nominee Director at Panacea Medical Technologies Private Limited (2021–2025) and Director at Maxxess Technology Private Limited (2018–2024) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Qure.Ai Technologies Private Limited U74999MH2016PTC283891 | Director | 13 Apr 2022 | 2016 | ₹190 Cr (FY 2025) | Active |
 Neonatal Care & Research Institute Private Limited U85110KA2011PTC060298 | Nominee Director | 29 Sep 2021 | 2011 | ₹134 Cr (FY 2025) | Active |
 Sekhmet Technologies Private Limited U72200HR2015PTC056692 | Nominee Director | 25 Mar 2021 | 2015 | ₹78.09 Cr (FY 2025) | Active |
 Lilac Insights Private Limited U85191MH2011PTC217513 | Director | 14 Jul 2017 | 2011 | ₹77.23 Cr (FY 2025) | Active |
 Touchkin Eservices Private Limited U72200KA2015PTC078356 | Nominee Director | 01 Sep 2022 | 2015 | ₹47.31 Cr (FY 2025) | Active |
 Healthquad Capital Advisors Private Limited U74999DL2019PTC352056 | Director | 13 Nov 2019 | 2019 | ₹21.02 Cr (FY 2025) | Active |
 Neurosynaptic Communications Private Limited U73100KA2002PTC031023 | Nominee Director | 08 Oct 2021 | 2002 | ₹9.78 Cr (FY 2025) | Active |
 Kois India Investment Advisors Private Limited U74999MH2017PTC292186 | Director | 08 Mar 2017 | 2017 | ₹6.24 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Panacea Medical Technologies Private Limited U33112KA1999PTC079963 | Nominee Director | 05 Oct 2021 | 1999 | ₹99.58 Cr (FY 2025) | Active |
 Maxxess Technology Private Limited U74999MH2017PTC289641 | Director | 01 Mar 2018 | 2017 | ₹15,528 (FY 2020) | Under Process Of Striking Off |
 Regency Hospital Limited U85110UP1987PLC008792 | Nominee Director | 28 Feb 2017 | 1987 | ₹562 Cr (FY 2025) | Active |
 Organisation Of Pharmaceutical Producers Of India U91120MH1965GAP013389 | Director | 19 Sep 2008 | 1965 | ₹15.58 Cr (FY 2025) | Active |
| Indo-Belgian Luxembourg Chamber Of Commerce And Industry U91120MH2001NPL132596 | Director | 28 Nov 2007 | 2001 | ₹7.7 Lakh (FY 2023) | Active |
| Ucb India Private Limited U62090MH1959PTC011545 | Managing Director | 28 Feb 2007 | 1959 | ₹32.54 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Charles Antoine Janssen
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Charles Antoine Janssen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Charles Antoine Janssen
Charles Antoine Janssen currently holds 9 directorships: Qure.Ai Technologies Private Limited (Director, since 13 Apr 2022, revenue ₹190 Cr (FY 2025)); Neonatal Care & Research Institute Private Limited (Nominee Director, since 29 Sep 2021, revenue ₹134 Cr (FY 2025)); Sekhmet Technologies Private Limited (Nominee Director, since 25 Mar 2021, revenue ₹78.09 Cr (FY 2025)); Lilac Insights Private Limited (Director, since 14 Jul 2017, revenue ₹77.23 Cr (FY 2025)); Touchkin Eservices Private Limited (Nominee Director, since 01 Sep 2022, revenue ₹47.31 Cr (FY 2025)); and 4 more.
Charles Antoine Janssen was first appointed on 28 Feb 2007 as Managing Director at Ucb India Private Limited. The most recent appointment on record is 01 Sep 2022 at Touchkin Eservices Private Limited.
The 9 current companies of Charles Antoine Janssen that report revenue have a combined latest revenue of ₹566 Cr: Qure.Ai Technologies Private Limited ₹190 Cr (FY 2025); Neonatal Care & Research Institute Private Limited ₹134 Cr (FY 2025); Sekhmet Technologies Private Limited ₹78.09 Cr (FY 2025); Lilac Insights Private Limited ₹77.23 Cr (FY 2025); Touchkin Eservices Private Limited ₹47.31 Cr (FY 2025); and 4 more.
Charles Antoine Janssen held 6 earlier board appointments: Panacea Medical Technologies Private Limited (Nominee Director, 05 Oct 2021 to 22 Jan 2025); Maxxess Technology Private Limited (Director, 01 Mar 2018 to 06 May 2024); Regency Hospital Limited (Nominee Director, 28 Feb 2017 to 08 Nov 2023); Organisation Of Pharmaceutical Producers Of India (Director, 19 Sep 2008 to 19 Mar 2010); Indo-Belgian Luxembourg Chamber Of Commerce And Industry (Director, 28 Nov 2007 to 27 Sep 2010); and 1 more.
The current boards of Charles Antoine Janssen's companies include Amit Kakar (Qure.Ai Technologies Private Limited), Anushree Ashis Saha (Qure.Ai Technologies Private Limited), Chintamani Aniruddha Bhagat (Qure.Ai Technologies Private Limited), Devtosh Kumar Khare (Qure.Ai Technologies Private Limited), Harsh Vaish (Qure.Ai Technologies Private Limited), Prashant Warier (Qure.Ai Technologies Private Limited), among others.